logo

For the Inventor, By the Inventor

Agoura Hills, CA, United States of America

A2 Biotherapeutics, Inc.

Calculating rank
USPTO Granted Patents = 16


Trademarks = 1

Forward Citations = 11

Loading Chart...
Loading Chart...

14 inventors (with patents filed for the assignee):

goldMedal Carl Alexander Kamb (10 out of 10 patents)

silverMedal Agnes Eva Hamburger (6 out of 36 patents)

bronzeMedal Alexander Kamb (6 out of 6 patents)

4.  Breanna Diandreth (4 out of 4 patents)

5.  Mark E Daris (4 out of 8 patents)

6.  Kiran Deshmukh (4 out of 4 patents)

7.  Han Xu (4 out of 4 patents)

8.  Dora Toledo Warshaviak (3 out of 3 patents)

9.  Xueyin Wang (2 out of 2 patents)

10.  Mark L Sandberg (2 out of 2 patents)

11.  Julyun Oh (2 out of 2 patents)

12.  Talar Tokatlian (1 out of 1 patent)

13.  Yuta Ando (1 out of 1 patent)

14.  Jee Young Mock (1 out of 1 patent)


16 patents:

1. 12599665 - GENE FUSIONS FOR CONTROL OF GENETICALLY MODIFIED CELLS (2026-04-14),
2. 12595291 - ENGINEERED IMMUNE CELLS WITH MICRO-CLUSTERS (2026-04-07),
3. 12534509 - ENGINEERED IMMUNE CELLS WITH RECEPTOR CROSS-TALK (2026-01-27),
4. 12459983 - Engineered immune cells with receptor signal strength modulated by a hinge (2025-11-04),
5. 12435124 - Compositions and methods for treating CEACAM positive cancers (2025-10-07),
6. 12215134 - Engineered immune cells with dominant signals (2025-02-04),
7. 12195513 - LILRB1-based chimeric antigen receptor (2025-01-14),
8. 12187775 - LILRB1-based chimeric antigen receptor (2025-01-07),
9. 12037377 - LILRB1-based chimeric antigen receptor (2024-07-16),
10. 12012612 - Engineered immune cells with receptor signal strength modulated by a hinge (2024-06-18),
11. 11976297 - Engineered immune cells with receptor cross-talk (2024-05-07),
12. 11730764 - Compositions and methods for treating HER2 positive cancers (2023-08-22),
13. 11602544 - Compositions and methods for treating EGFR positive cancers (2023-03-14),
14. 11602543 - Compositions and methods for treating mesothelin positive cancers (2023-03-14),
15. 11433100 - Compositions and methods for treating ceacam positive cancers (2022-09-06),
Company Overview
A2 Biotherapeutics, Inc. is a biotechnology company based in Agoura Hills, California, focused on developing innovative cell therapies for cancer treatment. The company specializes in engineering T cells to target and eliminate tumors while minimizing damage to healthy tissues. A2 Biotherapeutics leverages advanced technologies in immunotherapy and genetic engineering to create therapies that aim to improve patient outcomes in oncology. Their research is dedicated to addressing unmet medical needs in cancer care through precision medicine.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Nov 3 2026

16 Patents

#4 in Agoura Hills, CA

#4,788 in California

#19,954 in US

#37,914 in the World

Agoura Hills, CA (US)
Agoura Hills, CA, United States of America

A2 Biotherapeutics, Inc.

Forward Citations = 11

14 inventors:

goldMedal Carl Alexander Kamb (10 out of 10 patents)

silverMedal Agnes Eva Hamburger (6 out of 36 patents)

bronzeMedal Alexander Kamb (6 out of 6 patents)

4.  Breanna Diandreth (4 out of 4 patents)

5.  Mark E Daris (4 out of 8 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: A2 Biotherapeutics, Inc.. Retrieved from https://idiyas.com/company/a2-biotherapeutics

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…